Why the study?
The IPDfromKM method is generally used for superiority analyses, but whether it can be applied to non-inferiority analyses lacked supporting studies.
Are implantable devices occluding the left atrial appendage non-inferior to warfarin in patients with atrial fibrillation when analyzed using the IPDfromKM method?
Are implantable devices occluding the left atrial appendage non-inferior to warfarin in patients with atrial fibrillation when analyzed using the IPDfromKM method?
The IPDfromKM method can be successfully applied for non-inferiority analyses, as demonstrated by confirming the non-inferiority of LAA occlusion devices compared to warfarin in atrial fibrillation.
Validates IPDfromKM for non-inferiority; extends method utility to indirect comparisons beyond superiority analyses.
The IPDfromKM method, or Shiny method, is an artificial intelligence tool that enables indirect comparisons between studies by reconstructing individual patient data (IPD) from Kaplan-Meier (KM) curves. The IPDfromKM method is generally used for superiority analyses, but a further application could be represented by non-inferiority analyses. However, there are no studies supporting this methodological hypothesis. The aim of this work was to validate the IPDfromKM method for non-inferiority analyses by "exploiting" the well-described non-inferiority of implantable devices occluding the left atrial appendage compared to oral anticoagulants in patients with atrial fibrillation. We performed a systematic review searching for randomized controlled trials (RCTs) in the PubMed database and found five studies. The R software (version 4.3.3) was used to perform a standard survival analysis comparing Watchman and Amlet devices with warfarin. The hazard ratio (HR), with 95% confidence interval (CI), was the main parameter of our analysis. The results confirmed the non-inferiority of Amlet and Watchman compared to warfarin (HR of Watchman vs. warfarin: 1.23, 95% CI 0.80 to 1.9; HR of Amlet vs. warfarin: 1.05, 95% CI 0.61 to 1.80). Therefore, we proposed a new application of the IPDfromKM method that could be potentially relevant in decision-making for the management of this common cardiac arrhythmia and a wide range of other pathological conditions.
No takes yet. Share an insight, caveat, or question.
Piragine et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: